Skip to main content

Advertisement

SpringerLink
Log in

Correlation of quality of life with tumor response in patients receiving palliative chemotherapy for advanced gastrointestinal tumors

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

We prospectively evaluated the association of tumor response with change of quality of life (QOL) in patients with advanced gastrointestinal tumors receiving palliative chemotherapy. Out of 133 eligible patients, 90 (68%) completed the European Organization for Research and Treatment Quality of Life Questionnaire C-30 (EORTC QLQ C-30) at baseline and at regular intervals during palliative chemotherapy. Among the 90 available patients, 88 patients could be evaluated for response, and 32 (36%) responded. Taking into account 32 patients who had stable disease, 64 (73%) achieved a clinical benefit, defined as an objective response or stable disease. Improvement in the emotional functioning or global QOL was observed before the fourth cycle of chemotherapy in responders (P = 0.039) and patients with clinical benefit (P = 0.026). Grade 3 or 4 toxic effects occurred in 39% of patients; however, this did not adversely affect the global or other domains of QOL. Therefore, change of QOL during the chemotherapy was closely related with clinical outcomes. We should apply the QOL assessment to all patients who received palliative chemotherapy for their gastrointestinal tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ministry of Health and Welfare, and Central and Regional Cancer Registry Center. Cancer Incidence in Korea: 1998–2002. (http://www.ncc.re.kr/) Last accessed May 2007.

  2. Bae JM, et al. Annual report of the Central Cancer Registry in Korea-1999: based on registered data from 128 hospitals. J Korean Cancer Assoc 2001;33:367–72.

    Google Scholar 

  3. American Society of Clinical Oncology. Outcomes of caner treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 1995;14:671–9.

    Google Scholar 

  4. Aaronson NK, et al. The European Organization for Research and Treatment of Cancer EORTC QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:3653–76.

    Article  Google Scholar 

  5. Yun YH, et al. Validation of the Korean version of the EORTC QLQ-C30. Qual Life Res 2004;13:863–8.

    Article  PubMed  CAS  Google Scholar 

  6. Zigmund AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–70.

    Article  Google Scholar 

  7. Fayers PM, et al., editors. EORTC QLQ-C30 Scoring Manual, 3rd ed. EORTC Quality of Life Group: Brussels, 2001, pp 6–14. (http://www.eortc.be/home/qol/manuals.htm) Last accessed May 2007.

  8. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998;16:139–44.

    PubMed  CAS  Google Scholar 

  9. Cascinu S, Labianca R, Daniele B, Beretta G, Salvagni S. Survival and quality of life in gastrointestinal tumors: two different end points? Ann Oncol 2001;12(Suppl 3):S31–6.

    Article  PubMed  Google Scholar 

  10. Burris HA 3rd, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997;15:2403–13.

    PubMed  CAS  Google Scholar 

  11. Yun YH, et al. Economic burdens and quality of life of family caregivers of cancer patients. Oncology 2005;68:107–14.

    Article  PubMed  Google Scholar 

  12. Hensing TA, Peterman AH, Schell MJ, Lee JH, Socinski MA. Impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel. Cancer 2003;98:779–888.

    Article  PubMed  CAS  Google Scholar 

  13. Modi S, et al. Prospective exploratory analysis of the association between tumor response, quality of life, and expenditures among patients receiving paclitaxel monotherapy for refractory metastatic breast cancer. J Clin Oncol 2002;20:3665–73.

    Article  PubMed  CAS  Google Scholar 

  14. Conroy T, et al. Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival. Ann Oncol 2002;13:721–9.

    Article  PubMed  CAS  Google Scholar 

  15. Eton DT, et al. Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: results from Eastern Cooperative Oncology Group Study 5592. J Clin Oncol 2003;21:1536–43.

    Article  PubMed  Google Scholar 

  16. Roychowdhury DF, Hayden A, Liepa AM. Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer. J Clin Oncol 2003;21:673–8.

    Article  PubMed  CAS  Google Scholar 

  17. Fang FM, et al. Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy. Cancer 2004;100:425–32.

    Article  PubMed  Google Scholar 

  18. Chang VT, et al. Quality of life and survival: the role of multidimensional symptom assessment. Cancer 1998;83:173–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We appreciate the EORTC for permitting using the EORTC QLQ-C30 module to conduct our study. This work was presented in the 41st ASCO Annual Meeting in Orlando, Florida, USA, May 13–17, 2005.

Author information

Author notes

  1. Soo-Mee Bang

    Present address: Department of Internal Medicine, Seoul National University Bundang Hospital, 300 Gumi-dong, Bundang-gu, Seongnam-si, Gyeongi-do, 463-707, Korea

Authors and Affiliations

  1. Department of Internal Medicine, Gachon University of Medicine and Science Gil Hospital, Incheon, Korea

    Dong Bok Shin, Soo-Mee Bang, Se Hoon Park, Hee Geun Kang, Jung In Jue, Sang Hoon Han, Yuna Lee, Eun Kyung Cho & Jae Hoon Lee

  2. Department of Internal Medicine, Gachon Medical School, Gil Medical Center, Incheon, 405-760, Korea

    Soo-Mee Bang

Authors
  1. Dong Bok Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Soo-Mee Bang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Se Hoon Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hee Geun Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jung In Jue
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sang Hoon Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yuna Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Eun Kyung Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jae Hoon Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Soo-Mee Bang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shin, D.B., Bang, SM., Park, S.H. et al. Correlation of quality of life with tumor response in patients receiving palliative chemotherapy for advanced gastrointestinal tumors. Med Oncol 25, 81–87 (2008). https://doi.org/10.1007/s12032-007-0045-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-007-0045-5

Keywords

Search

Navigation